| Medical and Health Sciences | 2021-2025 | 389 | CN 41 | 99.92 |
| Medical Physiology | Lifetime | 310 | CN 6 | 99.50 |
| Neuroscience of Neurology | Lifetime | 211 | CN 4 | 98.31 |
| Psychiatry and Mental health | Lifetime | 427 | CN 2 | 98.57 |
| Clinical Neurology | Lifetime | 846 | CN 15 | 94.82 |
| Geriatrics and Gerontology | Lifetime | 494 | CN 17 | 80.90 |
| Medical Physiology | 2021-2025 | 47 | CN 1 | 99.35 |
| Psychiatry and Mental health | 2021-2025 | 42 | CN 3 | 99.44 |
| Neuroscience of Neurology | 2021-2025 | 72 | CN 10 | 96.23 |
| Clinical Neurology | 2021-2025 | 234 | CN 8 | 93.28 |
| Epidemiology | 2021-2025 | 861 | CN 90 | 91.39 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 473 | CN 166 | 91.45 |
| Geriatrics and Gerontology | 2021-2025 | 181 | CN 8 | 76.50 |
| Alzheimer's disease research and treatments | Lifetime | 121 | CN 3 | 99.66 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 147 | CN 6 | 99.31 |
| Dementia and Cognitive Impairment Research | Lifetime | 184 | CN 2 | 99.39 |
| Inflammation biomarkers and pathways | Lifetime | 15 | CN 2 | 98.39 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 119 | CN 6 | 98.86 |
| Tryptophan and brain disorders | Lifetime | 425 | CN 8 | 97.91 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 402 | CN 15 | 97.07 |
| Folate and B Vitamins Research | Lifetime | 544 | CN 16 | 96.19 |
| Health, Environment, Cognitive Aging | Lifetime | 345 | CN 3 | 95.26 |
| S100 Proteins and Annexins | Lifetime | 540 | CN 10 | 95.19 |
| Nuclear Receptors and Signaling | Lifetime | 363 | CN 18 | 95.10 |
| Clusterin in disease pathology | Lifetime | 40 | CN 4 | 93.95 |
| Inflammasome and immune disorders | Lifetime | 784 | CN 84 | 93.86 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 733 | CN 26 | 93.68 |
| Ginkgo biloba and Cashew Applications | Lifetime | 802 | CN 123 | 78.06 |
| GDF15 and Related Biomarkers | Lifetime | 915 | CN 82 | 73.93 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 39 | CN 1 | 99.60 |
| Alzheimer's disease research and treatments | 2021-2025 | 43 | CN 1 | 99.45 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 17 | CN 6 | 97.75 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 85 | CN 25 | 97.85 |
| Health, Environment, Cognitive Aging | 2021-2025 | 36 | CN 2 | 97.46 |
| Nutritional Studies and Diet | 2021-2025 | 430 | CN 49 | 94.95 |
| S100 Proteins and Annexins | 2021-2025 | 79 | CN 9 | 89.24 |
| Tryptophan and brain disorders | 2021-2025 | 499 | CN 149 | 91.41 |
| Folate and B Vitamins Research | 2021-2025 | 143 | CN 40 | 88.61 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 607 | CN 64 | 93.49 |
| Genetic Associations and Epidemiology | 2021-2025 | 508 | CN 54 | 91.10 |
| Frailty in Older Adults | 2021-2025 | 862 | CN 87 | 88.66 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 682 | CN 151 | 87.55 |
| Inflammation biomarkers and pathways | 2021-2025 | 41 | CN 18 | 83.78 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 752 | CN 149 | 78.81 |
| Sleep and Wakefulness Research | 2021-2025 | 939 | CN 73 | 83.07 |
| Cerebrovascular and genetic disorders | 2021-2025 | 241 | CN 43 | 66.44 |
| Cancer-related cognitive impairment studies | 2021-2025 | 885 | CN 93 | 66.45 |
